Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
A survey by MSF and T1 International highlighted that insulin injected from pen devices is preferred by 82% of people with diabetes over insulin in vials injected with syringes, due to its accuracy, ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...